ALLMedicine™ Dermatologic Therapy Center

Jun 3rd, 2021 - An increasing use of beta-blockers in dermatology has been described over the last 10 years, despite the fact that their use in diseases other than infantile hemangiomas is off-label. This review discusses the emerging role of topical beta-blocker...

Jun 27th, 2019 - Skin conditions are among the most prevalent and disabling diseases affecting millions of people worldwide. Recently, there have been significant changes in dermatologic clinical practice. Advances in knowledge of disease pathophysiology have led ...

Jun 20th, 2019 - The aim of the current study was to report the efficacy of topical and systemic treatments for immune-related cutaneous adverse events (ircAEs) attributed to checkpoint inhibitors in an uncontrolled cohort of patients referred to oncodermatology c...

Mar 7th, 2019 - Persistent alopecia occurs in a subset of patients undergoing chemotherapy, yet the quality of life (QOL) of these patients and their response to therapy have not been described in a large patient cohort. To characterize the clinical presentation ...

INTRODUCTION — Psoriasis is a common chronic skin disorder typically characterized by erythematous papules and plaques with a silver scale, although other presentations occur. Most cases are not severe enough to affect general health and are treat...

Jun 12th, 2019 - Viewpoint This review provides a wealth of information about skin eruptions associated with ICI therapy. As use of these powerful immunotherapy drugs continues to expand, clinicians should familiarize themselves with the wide range of potential cu...

Aug 3rd, 2016 - The use of psychotropic medications was similar between patients seeking cosmetic dermatology treatment and those presenting with medical dermatologic conditions in a study published in the Journal of Drugs in Dermatology. A retrospective chart re.